ORD co-sponsored Scientific Conferences


Co-funding Institute(s):  National Human Genome Research Institute (NHGRI)


Should Newborn Screening be Considered for Gaucher Disease? , Spring 2009
NIH Campus, Bethesda, Maryland, United States
Contact for additional information: Jean Jenkins, PhD, RN, NHGRI 301-496-4601


Description
Goals of this conference are to (1) determine the feasibility of newborn screening for Gaucher disease, (2) explore the advisability and implications for such screening, and (3) attempt to reach a consensus on the subject or to make recommendations for future study.



Note: If you need help accessing information in different file formats such as PDF, MP3, see Viewers, Players, and Plug-ins.